Inventor · disambiguated record
Gabriel Nistor
Also filed as: NISTOR GABRIEL · NISTOR GABRIEL I
8 granted patents·19 pending applications·72 citations·filing 2003–2025
85Inventor score
Files withAIVITA BIOMEDICAL INC10NEOSTEM ONCOLOGY LLC6NISTOR GABRIEL4CALIFORNIA STEM CELL INC2UNIV CALIFORNIA2
Top patents by PatentIndex Score
27 records- 0192US7579188B2Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injuryUNIV CALIFORNIA·Filed 2006·Granted Aug 25, 2009·22 cites·22 claims
- 0286US8569061B2Stem cell growth media and methods of making and using sameNISTOR GABRIEL·Filed 2011·Granted Oct 29, 2013·8 cites·10 claims
- 0386US7285415B2Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injuryUNIV CALIFORNIA·Filed 2003·Granted Oct 23, 2007·30 cites·11 claims
- 0482US8153427B2Cardiomyocytes and methods of producing and purifying cardiomyocytesNISTOR GABRIEL·Filed 2008·Granted Apr 10, 2012·5 cites·19 claims
- 0582US7977096B2Stem cell growth media and methods of making and using sameCALIFORNIA STEM CELL INC·Filed 2008·Granted Jul 12, 2011·6 cites·74 claims
- 0678US12268770B2Use of cell membrane-bound signaling factorsAIVITA BIOMEDICAL INC·Filed 2023·Granted Apr 8, 2025·0 cites·17 claims
- 0778US11666522B2Use of cell membrane-bound signaling factorsAIVITA BIOMEDICAL INC·Filed 2018·Granted Jun 6, 2023·1 cites·24 claims
- 0874US2025288512A1Use of cell membrane-bound signaling factorsAIVITA BIOMEDICAL INC·Filed 2024·Application pending·0 cites
- 0970US2025236841A1Methods to enhance tumor immunogenicity and compositions for autologous cancer immunotherapeutic products using modified tumor cells and modified dendritic cellsAIVITA BIOMEDICAL INC·Filed 2024·Application pending·0 cites
- 1064US2025387314A1Use of cell membrane-bound signaling factorsAIVITA BIOMEDICAL INC·Filed 2025·Application pending·0 cites
- 1163US2022347277A1Methods to Enhance Tumor Immunogenicity and Compositions for Autologous Cancer Immunotherapeutic Products Using Modified Tumor Cells and Modified Dendritic CellsAIVITA BIOMEDICAL INC·Filed 2022·Application pending·0 cites
- 1262US2020332254A1Oligodendrocytes Derived from Human Embryonic Stem Cells for Remyelination and Treatment of Spinal Cord InjuryTHE REGENTS OF THE UNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1360US2019358145A1Use of cell membrane-bound signaling factorsAIVITA BIOMEDICAL INC·Filed 2017·Application pending·0 cites
- 1459US10611998B2Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injuryKEIRSTEAD HANS S·Filed 2009·Granted Apr 7, 2020·0 cites·16 claims
- 1557US2023210982A1Autologous dendritic cell vaccine kit and usesAIVITA BIOMEDICAL INC·Filed 2022·Application pending·0 cites
- 1655US2020330367A1Stem cell compositions for cosmetic and dermatologic useNEOSTEM ONCOLOGY LLC·Filed 2020·Application pending·0 cites
- 1753US2005101014A1Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injuryFiled 2003·Application pending·0 cites
- 1852US2020230219A1Methods to Enhance Tumor Immunogenicity and Compositions for Autologous Cancer Immunotherapeutic Products Using Modified Tumor Cells and Modified Dendritic CellsAIVITA BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 1948US2012213748A1Cardiomyocytes and methods of producing and purifying cardiomyocytesNISTOR GABRIEL·Filed 2012·Application pending·0 cites
- 2046US2022268775A1Soluble programmed cell death protein-1 as a biomarker in cancer patientsAIVITA BIOMEDICAL INC·Filed 2020·Application pending·0 cites
- 2140US2018116951A1Stem cell compositions for cosmetic and dermatologic useNEOSTEM ONCOLOGY LLC·Filed 2016·Application pending·0 cites
- 2239US2015322397A1Bioreactor Cartridge and SystemCALIFORNIA STEM CELL INC·Filed 2013·Application pending·0 cites
- 2339US2013344598A1Neural cell purification for transplantationNISTOR GABRIEL·Filed 2012·Application pending·0 cites
- 2439US2016058855A1High purity ovarian cancer stem cells for active autologous immune therapyNEOSTEM ONCOLOGY LLC·Filed 2014·Application pending·0 cites
- 2534US2016017293A1Individualized high purity hepatocellular carcinoma stem cells, methods and use of the sameNEOSTEM ONCOLOGY LLC·Filed 2014·Application pending·0 cites
- 2634US2016030537A1Individualized High Purity Glioblastoma Multiforme Stem Cells and Methods for Stimulating Immune ResponseNEOSTEM ONCOLOGY LLC·Filed 2014·Application pending·0 cites
- 2734US2016022789A1Individualized high purity colon carcinoma stem cells, methods and use of the sameNEOSTEM ONCOLOGY LLC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gabriel Nistor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →